|
| | Preview | Issue Date | Title | Author(s) |
| 1 | | 26-Mar-2024 | How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials? | Tiong, Ing Soo; Wall, Meaghan; Bajel, Ashish; Kalro, Akash; Fleming, Shaun; Roberts, Andrew W; Thiagarajah, Nisha; Chua, Chong Chyn; Latimer, Maya; Yeung, David; Marlton, Paula; Johnston, Amanda; Enjeti, Anoop; Fong, Chun Yew; Cull, Gavin; Larsen, Stephen; Kennedy, Glen; Schwarer, Anthony; Kipp, David; Ramanathan, Sundra; Verner, Emma; Tiley, Campbell ; Morris, Edward; Hahn, Uwe; Moore, John; Taper, John; Purtill, Duncan; Warburton, Pauline; Stevenson, William; Murphy, Nicholas J ; Tan, Peter; Beligaswatte, Ashanka; Mutsando, Howard; Hertzberg, Mark; Shortt, Jake; Szabo, Ferenc; Dunne, Karin; Wei, Andrew H |
| 2 | | 7-Dec-2023 | Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG | Loo, Sun; Roberts, Andrew W; Anstee, Natasha S; Kennedy, Glen A; He, Simon; Schwarer, Anthony P; Enjeti, Anoop K; D'Rozario, James; Marlton, Paula; Bilmon, Ian A; Taper, John; Cull, Gavin; Tiley, Campbell ; Verner, Emma; Hahn, Uwe; Hiwase, Devendra K; Iland, Harry J; Murphy, Nick; Ramanathan, Sundra; Reynolds, John; Ong, Doen Ming; Tiong, Ing Soo; Wall, Meaghan; Murray, Michael; Rawling, Tristan; Leadbetter, Joanna; Rowley, Leesa; Latimer, Maya; Yuen, Sam; Ting, Stephen B; Fong, Chun Yew; Morris, Kirk; Bajel, Ashish; Seymour, John F; Levis, Mark J; Wei, Andrew H |
| 3 | | 13-Oct-2023 | A population-based family case-control study of sun exposure and follicular lymphoma risk | Odutola, Michael K; van Leeuwen, Marina T; Bruinsma, Fiona; Turner, Jennifer; Hertzberg, Mark; Seymour, John F; Prince, H Miles; Trotman, Judith; Verner, Emma; Roncolato, Fernando; Opat, Stephen; Lindeman, Robert; Tiley, Campbell ; Milliken, Samuel T; Underhill, Craig R; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 4 | | Oct-2023 | Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study | Odutola, Michael K; van Leeuwen, Marina T; Bruinsma, Fiona J; Benke, Geza; Turner, Michelle C; Trotman, Judith; Turner, Jennifer; Seymour, John F; Prince, H Miles; Milliken, Samuel T; Tiley, Campbell ; Hertzberg, Mark; Roncolato, Fernando; Opat, Stephen; Lindeman, Robert; Verner, Emma; Underhill, Craig R; Cardis, Elisabeth; Giles, Graham; Vajdic, Claire M |
| 5 | | Jan-2023 | Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control study | Odutola, Michael K; van Leeuwen, Marina T; Bassett, Julie K; Bruinsma, Fiona; Turner, Jennifer; Seymour, John F; Prince, Henry Miles; Milliken, Samuel T; Hertzberg, Mark; Roncolato, Fernando; Opat, Stephen S; Lindeman, Robert; Tiley, Campbell ; Trotman, Judith; Verner, Emma; Harvey, Michael; Underhill, Craig R; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 6 | | 7-Oct-2022 | Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma | Nath, Christa Ellen; Grigg, Andrew; Rosser, Sebastian P A; Estell, Jane; Newman, Elizabeth; Tiley, Campbell ; Ramanathan, Sundra; Ho, Shir Jing; Larsen, Stephen; Gibson, John; Presgrave, Peter ; Shaw, Peter John; Trotman, Judith |
| 7 | | Oct-2022 | Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study | Odutola, Michael K; van Leeuwen, Marina T; Turner, Jennifer; Bruinsma, Fiona; Seymour, John F; Prince, H Miles; Milliken, Samuel T; Hertzberg, Mark; Trotman, Judith; Opat, Stephen S; Lindeman, Robert; Roncolato, Fernando; Verner, Emma; Harvey, Michael; Tiley, Campbell ; Underhill, Craig R; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 8 | | 30-May-2022 | Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia | Odutola, Michael K; van Leeuwen, Marina T; Turner, Jennifer; Bruinsma, Fiona; Seymour, John F; Prince, Henry M; Milliken, Samuel T; Trotman, Judith; Verner, Emma; Tiley, Campbell ; Roncolato, Fernando; Underhill, Craig R; Opat, Stephen S; Harvey, Michael; Hertzberg, Mark; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 9 | | Aug-2021 | Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement | Tiley, Campbell ; Hamad, N.; Ananda-Rajah, M.; Gilroy, N.; MacIntyre, R.; Gottlieb, D.; Ritchie, D.; Harrison, S.; Kennedy, G.; Watson, A.M.; Greenwood, M.; Doocey, R.; Perera, T.; Spencer, A.; Wong, E.; O'Brien, T.; Shaw, P.; Conyers, R.; Milliken, S.; Bardy, P.; Larsen, S.; Ho, P.J.; Lai, H.; Bajel, A.; Butler, J.; D'Rozario, J.; Johnston, A.; Cochrane, T.; Mills, T.; Irving, I.; Pullon, H.; Purtill, D. |
| 10 | | Sep-2020 | Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamics | Tiley, Campbell ; Nath, C.E.; Trotman, J.; Nivison-Smith, I.; Gurney, H.; Zeng, L.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; McLachlan, Andrew ; Shaw, P.J. |
| 11 | | Dec-2019 | A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons | Tiley, Campbell ; Stevenson, W.; Bryant, J.; Watson, R.; Sanson-Fisher, R.; Oldmeadow, C.; Henskens, F.; Brown, C.; Ramanathan, S.; Enjeti, A.; Guest, J.; Tzelepis, F.; Paul, C.; D'Este, C. |
| 12 | | May-2017 | Raccoon eyes in systemic light chain amyloidosis | Forsyth, Cecily J ; Tiley, Campbell |
| 13 | | May-2017 | Idarubicin dose escalation during consolidation therapy for adult Acute Myeloid Leukemia | Tiley, Campbell ; Bradstock, K.F.; Link, E.; Di Iulio, J.; Szer, J.; Marlton, P.; Wei, A.H.; Enno, A.; Schwarer, A.; Lewis, I.D.; D'Rozario, J.; Coyle, L.; Cull, G.; Campbell, P.; Leahy, M.F.; Hahn, U.; Cannell, P.; Lowenthal, R.M.; Moore, J.; Cartwright, K.; Cunningham, I.; Taper, J.; Grigg, A.; Roberts, A.W.; Benson, W.; Hertzberg, M.; Deveridge, S.; Rowlings, P.; Mills, A.K.; Gill, Devinder S ; Bardy, P.; Campbell, L.J.; Seymour, J.F. |
| 14 | | Jul-2016 | High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation | Tiley, Campbell ; Nath, C.E.; Trotman, J.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; Kwan, Y.L.; Gurney, H.; McLachlan, Andrew ; Earl, J.W.; Nivison-Smith, I.; Zeng, L.; Shaw, P.J. |
| 15 | | Sep-2015 | Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial | Tiley, Campbell ; Iland, H.J.; Collins, M.; Bradstock, K.F.; Supple, S.G.; Catalano, A.; Hertzberg, M.; Browett, P.; Grigg, A.; Firkin, F.; Campbell, L.J.; Hugman, A.; Reynolds, J.; Di Iulio, J.; Taylor, K.; Filshie, R.; Seldon, M.; Taper, J.; Szer, J.; Moore, J.; Bashford, J.; Seymour, J.F. |
| 16 | | Jun-2015 | Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies | Tiley, Campbell ; Lynagh, M.C.; Clinton-McHarg, T.; Hall, A.; Sanson-Fisher, R.; Stevenson, W.; Bisquera, A. |
| 17 | | Aug-2012 | All-Trans-Retinoic Acid, Idarubicin, and IV Arsenic Trioxide as initial therapy in Acute Promyelocytic Leukemia (APML4) | Iland, H.J.; Bradstock, K.F.; Supple, S.G.; Catalano, A.; Collins, M.; Hertzberg, M.; Browett, P.; Grigg, A.; Firkin, F.; Hugman, A.; Reynolds, J.; Di Iulio, J.; Tiley, Campbell ; Taylor, K.; Filshie, R.; Seldon, M.; Taper, J.; Szer, J.; Moore, J.; Bashford, J.; Seymour, J.F. |
| 18 | | Jun-2012 | A Phase II Study of Risk-Adapted Intravenous Melphalan in patients with AL Amyloidosis | Mollee, P.; Tiley, Campbell ; Cunningham, I.; Moore, J.; Prince, M.; Cannell, P.; Gibbons, S.; Tate, J.; Paul, S.; Mar Fan, H.; Gill, Devinder S |
| 19 | | May-2010 | Population Pharmacokinetics of Melphalan in Patients with Multiple Myeloma Undergoing High Dose Therapy | Nath, C.E.; Shaw, P.J.; Trotman, J.; Zeng, L.; Duffull, S.; Hegarty, G.; McLachlan, Andrew ; Gurney, H.; Kerridge, Ian ; Kwan, Yiu Lam ; Presgrave, P.; Tiley, Campbell ; Joshua, D.; Earl, J.W. |
| 20 | | Feb-2010 | Enrollment of Patients to Clinical Trials in Haematological Cancer in New South Wales: Current Status, Perceived Barriers and Opportunities for Improvement | Murray, P.; Kerridge, Ian ; Tiley, Campbell ; Catanzariti, A.; Welberry, H.; Lean, C.; Sinclair, S.; Bishop, J.; Bradstock, K.F. |
| 21 | | Apr-2008 | Consensus Guidelines for 'Rainy Day' Autologous Stem Cell Harvests in New South Wales | Trotman, J.; Presgrave, Peter ; Kwan, Yiu Lam ; Tiley, Campbell ; Estell, J.; Watson, A.M.; O'Brian, T.A.; Peters, D. |
| 22 | | 1991 | Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor | Tiley, Campbell ; Powles, R.; Teo, C.P.; Treleaven, J.; Findlay, M.; Hewetson, M. |
| 23 | | 1991 | How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease | Tiley, Campbell ; Powles, R.; Treleaven, J.; Millar, J.; Gordon-Smith, E.; Findlay, M.; Teo, C.; Duncombe, A.; Robinson, G. |
| 24 | | Dec-1990 | Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial | Tiley, Campbell ; Powles, R.; Smith, C.; Milan, S.; Treleaven, J.; Millar, J.; McElwain, T.; Gordon-Smith, E.; Miliken, S. |
| 25 | | Jun-1989 | Therapy-induced drug resistance in a human leukemia line (LALW-2). A clinically relevant model | Tiley, Campbell ; White, L.; Haber, M.; Brian, M.J.; Norris, M.D.; Trickett, A.; Sosula, L.; Stewart, B.W. |
Loading...
2
0
20
0
false